Subject
Pulmonary and Respiratory Medicine,Oncology
Reference3 articles.
1. Clinicopathologic and genomic factors impacting efficacy of first-line chemoimmunotherapy in advanced NSCLC;Alessi;J Thorac Oncol,2023
2. Diminished efficacy of programmed death-(ligand)1 inhibition in STK11- and KEAP1-mutant lung adenocarcinoma is affected by KRAS mutation status;Ricciut;J Thorac Oncol,2022
3. Clinical efficacy of atezolizumab plus bevacizumab and chemotherapy in KRAS-mutated non-small cell lung cancer with STK11, KEAP1, or TP53 comutations: subgroup results from the phase III IMpower150 trial;West;J Immunother Cancer,2022